RSA is pleased to highlight the contribution of Dick Lewis to the scientific paper“Scientific perspectives on in vivo developmental neurotoxicity testing: study design, regulatory context, and future directions.”
The paper explores the scientific and regulatory considerations surrounding developmental neurotoxicity (DNT) testing, examining current testing guidelines, differences in study design and the regulatory requirements that determine when these assessments are needed.
Developmental neurotoxicity testing plays an important role in evaluating the potential effects of chemical exposure on the developing nervous system. The paperconsiders the current regulatory landscape and identifies important considerations for the future development and application of these testing approaches.
Dick’s involvement reflects RSA’s commitment to contributing scientific expertise and supporting informed discussion on complex toxicological and regulatory issues.
If you’d like to read the full paper follow the link below: